SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.550
+0.020 (1.31%)
At close: Nov 24, 2025, 4:00 PM EST
1.570
+0.020 (1.28%)
After-hours: Nov 24, 2025, 7:59 PM EST
SLS Market Cap
SLS has a market cap or net worth of $220.79 million as of November 24, 2025. Its market cap has increased by 195.86% in one year.
Market Cap
220.79M
Enterprise Value
177.06M
1-Year Change
195.86%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since January 2, 2018, SLS's market cap has increased from $38.66M to $220.79M, an increase of 471.04%. That is a compound annual growth rate of 24.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 217.94M | 197.74% |
| Dec 31, 2024 | 73.20M | 115.37% |
| Dec 29, 2023 | 33.99M | -30.05% |
| Dec 30, 2022 | 48.59M | -44.69% |
| Dec 31, 2021 | 87.85M | 59.80% |
| Dec 31, 2020 | 54.97M | 162.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |